An Open-Label Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn’s Disease (Holiday)

$An Open-Label Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn’s Disease (Holiday)$

Recruiting

18 years - 64 years

All

1 Location

Brief description of study

You are being asked to take part in this research study because you have Crohn’s disease and the medical treatments you have tried have not brought you to full remission (clinically and physically symptom-free).

Detailed description of study

If you agree to take part, your participation will last for 6-7 months and will involve 5 study visits each of approximately 60 minutes in length and 3 telephone calls each of approximately 30 minutes in length. You might be eligible to participate in this trial if: 1. You have Crohn’s Disease 2. You are between the ages of 18-64 3. You have tried multiple therapies with NO relief 4. You failed 8 weeks of: • Azathioprine • 6-mercaptopureine • Methotrexate • Adalimumab • Certolizumab • Golimumab • Infliximab • Natalizumab OR • Vedolizumab

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Inflammatory Bowel Diseases, crohns
Age: 18 years - 64 years
Gender: All

Updated on 19 Feb 2024. Study ID: 823635

Find a site

Send a message

Enter your contact details to connect with study team

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).